Abstract
The LaryngoscopeVolume 117, Issue 7 p. 1319-1319 Article In reference to Topical Pimecrolimus 1% for the Treatment of Pruritic External Auditory Canals Hamid R. Djalilian MD, Hamid R. Djalilian MD Department of Otolaryngology-Head and Neck Surgery, University of California Irvine, Irvine, California; Academic Dermatology and Skin Cancer Institute, Chicago, IllinoisSearch for more papers by this authorOmeed Memar MD, PhD, Omeed Memar MD, PhD Department of Otolaryngology-Head and Neck Surgery, University of California Irvine, Irvine, California; Academic Dermatology and Skin Cancer Institute, Chicago, IllinoisSearch for more papers by this author Hamid R. Djalilian MD, Hamid R. Djalilian MD Department of Otolaryngology-Head and Neck Surgery, University of California Irvine, Irvine, California; Academic Dermatology and Skin Cancer Institute, Chicago, IllinoisSearch for more papers by this authorOmeed Memar MD, PhD, Omeed Memar MD, PhD Department of Otolaryngology-Head and Neck Surgery, University of California Irvine, Irvine, California; Academic Dermatology and Skin Cancer Institute, Chicago, IllinoisSearch for more papers by this author First published: 02 January 2009 https://doi.org/10.1097/MLG.0b013e318062114aRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume117, Issue7July 2007Pages 1319-1319 RelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
